相关实验视频

Updated: Jun 19, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

结构性大脑网络的病理基质帕金森病死者的弹性和拓学帕金森病死者

Irene Frigerio¹, Tommy A A Broeders¹, Chen-Pei Lin¹

¹From the Department of Anatomy and Neurosciences (I.F., T.A.A.B., C.-P.L., M.M.A.B., I.K., W.D.J.V.D.B., L.D., L.E.J.), and Department of Radiology and Nuclear Medicine (F.B.), Amsterdam UMC location Vrije Universiteit Amsterdam, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, United Kingdom; and Department of Neurology (H.W.B.), Amsterdam UMC location Vrije Universiteit Amsterdam, the Netherlands.

|July 23, 2024

概括

帕金森病 (PD) 脑网络对干扰的弹性降低,这并非直接来自局部病理,而是与广泛的α-synuclein积累有关. 这表明全球蛋白质传播会影响PD中的大脑网络组织.

科学领域:

神经科学是一个神经科学.
神经病理学神经病理学
医疗成像医学成像

背景情况:

帕金森病 (PD) 涉及α-synuclein (α-synuclein) 的传播,导致神经元损失和大脑网络中断.
扩散权重成像 (DWI) 提供大脑网络组织和弹性的测量.
了解神经病理对PD网络变化的贡献至关重要.

研究的目的:

为了研究PD中区域网络拓变化的基础的神经病理过程.
检查在帕金森病中促进大脑网络弹性因素.
为了将神经成像网络的测量与PD中的特定病理相关联.

主要方法:

在PD和对照大脑的综合死后MRI (T1加权,DWI) 和组织病理学.
概率曲谱用于评估网络拓 (自身向量中心性,集群系数) 和弹性.
在皮层区域的α-synuclein,tau,β-粉样蛋白,神经纤维光和synaptophysin的量化.

主要成果:

PD大脑显示了降低了对海马体环形状的自身向量中心性,与当地的病理学无关.
病发性脑网络表现出背前胰岛节点衰竭的弹性降低.
网络弹性降低与更高的Braakα-synuclein分期有关,而不是局部神经病理.

结论:

在PD中区域网络障碍是复杂的,不仅仅是由局部神经病理过程驱动的.
全球α-synuclein病理学显著影响帕金森病中的大脑网络重组.
需要进一步的研究,以充分阐明病理和PD中的网络动态之间的相互作用.

更多相关视频

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neuroplasticity

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.